|The somatic genomic landscape of chromophobe renal cell carcinoma|
CF Davis, CJ Ricketts, M Wang, L Yang, AD Cherniack, H Shen, C Buhay, ...
Cancer cell 26 (3), 319-330, 2014
|The transcriptional landscape and mutational profile of lung adenocarcinoma|
JS Seo, YS Ju, WC Lee, JY Shin, JK Lee, T Bleazard, J Lee, YJ Jung, ...
Genome research 22 (11), 2109-2119, 2012
|Human glioblastoma arises from subventricular zone cells with low-level driver mutations|
JH Lee, JE Lee, JY Kahng, SH Kim, JS Park, SJ Yoon, JY Um, WK Kim, ...
Nature 560 (7717), 243-247, 2018
|Patterns of somatic structural variation in human cancer genomes|
Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ...
Nature 578 (7793), 112-121, 2020
|Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing|
I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ...
Nature genetics 52 (3), 331-341, 2020
|Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas|
JK Lee, J Lee, S Kim, S Kim, J Youk, S Park, Y An, B Keam, DW Kim, ...
Journal of clinical oncology 35 (26), 3065-3074, 2017
|Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation|
MH Kim, J Kim, H Hong, SH Lee, JK Lee, E Jung, J Kim
The EMBO journal 35 (5), 462-478, 2016
|Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial|
SH Lee, JK Lee, MJ Ahn, DW Kim, JM Sun, B Keam, TM Kim, DS Heo, ...
Annals of Oncology 28 (2), 292-297, 2017
|Detecting the mutational signature of homologous recombination deficiency in clinical samples|
DC Gulhan, JJK Lee, GEM Melloni, I Cortes-Ciriano, PJ Park
Nature genetics 51 (5), 912-919, 2019
|Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking|
J Kim, H Jo, H Hong, MH Kim, JM Kim, JK Lee, WD Heo, J Kim
Nature communications 6 (1), 6781, 2015
|Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non–small cell lung cancer harboring wild-type epidermal growth factor receptor: a …|
JK Lee, S Hahn, DW Kim, KJ Suh, B Keam, TM Kim, SH Lee, DS Heo
Jama 311 (14), 1430-1437, 2014
|Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer|
KC Akdemir, VT Le, S Chandran, Y Li, RG Verhaak, R Beroukhim, ...
Nature genetics 52 (3), 294-305, 2020
|Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients|
HS Park, JK Lee, DW Kim, K Kulig, TM Kim, SH Lee, YK Jeon, DH Chung, ...
Lung cancer 77 (2), 288-292, 2012
|Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR …|
JK Lee, JY Shin, S Kim, S Lee, C Park, JY Kim, Y Koh, B Keam, HS Min, ...
Annals of oncology 24 (8), 2080-2087, 2013
|Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma|
JJK Lee, S Park, H Park, S Kim, J Lee, J Lee, J Youk, K Yi, Y An, IK Park, ...
Cell 177 (7), 1842-1857. e21, 2019
|Mechanisms and consequences of cancer genome instability: lessons from genome sequencing studies|
JK Lee, YL Choi, M Kwon, PJ Park
Annual Review of Pathology: Mechanisms of Disease 11, 283-312, 2016
|Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation|
JK Lee, TM Kim, Y Koh, SH Lee, DW Kim, YK Jeon, DH Chung, SC Yang, ...
Lung cancer 77 (2), 460-463, 2012
|A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling|
DHT Nguyen, E Lee, S Alimperti, RJ Norgard, A Wong, JJK Lee, ...
Science advances 5 (8), eaav6789, 2019
|Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT|
H Choi, JC Paeng, DW Kim, JK Lee, CM Park, KW Kang, JK Chung, ...
Lung Cancer 79 (3), 242-247, 2013
|Comparative analyses of overall survival in patients with anaplastic lymphoma kinase‐positive and matched wild‐type advanced nonsmall cell lung cancer|
JK Lee, HS Park, DW Kim, K Kulig, TM Kim, SH Lee, YK Jeon, DH Chung, ...
Cancer 118 (14), 3579-3586, 2012